US Stock MarketDetailed Quotes

ATHA Athira

Watchlist
  • 0.468
  • +0.028+6.39%
Close Feb 14 16:00 ET
  • 0.477
  • +0.009+1.99%
Post 19:21 ET
18.10MMarket Cap-0.16P/E (TTM)

About Athira Company

Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. The company was founded by Leen Kawas, John Wright, Lewis Rumpler, and Joseph Harding in March 2011 and is headquartered in Bothell, WA.

Company Profile

SymbolATHA
Company NameAthira
Listing DateSep 18, 2020
Issue Price17.00
Founded2011
CEODr. Mark J. Litton, PhD
MarketNASDAQ
Employees67
Fiscal Year Ends12-31
Address18706 North Creek Parkway,Suite 104
CityBothell
ProvinceWashington
CountryUnited States of America
Zip Code98011
Phone1-425-620-8501
Websitehttp://www.athira.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Mark J. Litton, PhD
  • Director, President and Chief Executive Officer
  • 2.26M
  • Dr. Kevin Church, PhD
  • Chief Scientific Officer
  • --
  • Robert Renninger
  • Principal Financial Officer, Principal Accounting Officer and Vice President, Finance
  • --
  • Grant E. Pickering
  • Independent Director
  • 96.53K
  • James A. Johnson
  • Independent Director
  • 106.87K
  • Dr. Michael A. Panzara, M.D.
  • Independent Director
  • 89.36K
  • Barbara Kosacz, J.D.
  • Independent Director
  • 102.39K
  • Joseph Edelman
  • Independent Director
  • 92.77K
  • John M. Fluke, Jr
  • Independent Director
  • 95.89K
  • Mark Worthington
  • General Counsel and Corporate Secretary
  • --
  • Kelly A. Romano
  • Chairwoman of the Board
  • 124.68K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
PILOT
831175
+30.00%
XINGANJIANG
873167
+29.99%
Beijing Highlander Digital Technology
300065
+20.05%
4
Hangzhou Gaoxin Materials Technology
300478
+20.02%
5
Shijihengtong Technology
301428
+20.01%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!